New eye injection shows promise for diabetic vision loss
Disease control
Completed
This phase 2 trial tested a new way to deliver dexamethasone directly to the back of the eye using tiny microspheres (OXU-001) compared to the standard Ozurdex implant. The study enrolled only 3 adults with diabetic macular edema to check safety and how well the treatment is tole…
Phase: PHASE2 • Sponsor: Oxular Limited • Aim: Disease control
Last updated Jun 26, 2026 13:03 UTC